β-catenin mRNA silencing and MEK inhibition display synergistic efficacy in preclinical tumor models

Colorectal carcinomas (CRC) harbor well-defined genetic abnormalities including aberrant activation of Wnt/β-catenin and MAPK pathways, often simultaneously. While the MAPK pathway can be targeted using potent small molecule drugs, including BRAF and MEK inhibitors, β-catenin inhibition has been his...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Cancer Ther
Huvudupphovsmän: Ganesh, Shanthi, Shui, Xue, Craig, Kevin P., Koser, Martin L., Chopda, Girish R., Cyr, Wendy A., Lai, Chengjung, Dudek, Henryk, Wang, Weimin, Brown, Bob D., Abrams, Marc T.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5805618/
https://ncbi.nlm.nih.gov/pubmed/29282298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-17-0605
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk